Business Type:Manufacturer
Main Products:Afatinib (diMaleate),Afatinib (diMaleate),Baricitinib,Regorafenib,Regorafenib monohydrate,Fostamatinib,R-406,LEE011,LEE011 (succinate),4,6-Dimethyl-2-mercaptopyrimidine,4,6-Dimethyl-2-methylsulfonylpyrimidine,7-NITRO-QUINOLINE,4-NITROPHENYLACETYLENE,sofosbuvir impurity
Country/Region:China
Annual Revenue:5000000 RMB
Year Established:2012
Main Markets:South America,Southeast Asia,Africa,Mid East,Eastern Asia,
Ddu Verified
HOT Rank
8/10